Mega-Dose vitamin c trial offers hope for Tough-to-Treat blood cancer
Disease control
Completed
This early-stage study tested whether adding very high doses of vitamin C (ascorbic acid) to a low dose of chemotherapy (melphalan) is safe and might help control advanced multiple myeloma. It involved 6 patients whose cancer had returned or stopped responding to multiple prior t…
Phase: PHASE1 • Sponsor: Christopher Strouse • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC